文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

印度ICU收治的1000例脓毒症患者多中心前瞻性登记研究(SEPSIS INDIA)

A multicentre prospective registry of one thousand sepsis patients admitted in Indian ICUs: (SEPSIS INDIA) study.
PubMed 文献 · Crit Care · 2024-11-19
一句话结论印度19个ICU的前瞻性登记显示:脓毒症住院病死率36.3%,脓毒症休克病死率50.8%,革兰阴性菌占65%、碳青霉烯耐药达50%,充分感染源控制、正确经验性抗生素和静脉硫胺素为保护因素。

该研究为多中心前瞻性脓毒症登记,采用Sepsis-3标准,在印度19个ICU历时一年(2022年8月至2023年7月)纳入1172例脓毒症患者(含500例脓毒症休克),排除新冠感染者。平均年龄65岁,男性61%,平均APACHE II 21分、SOFA 6.7分,以社区获得性感染为主、肺部最常见。培养阳性中65%为革兰阴性菌,革兰阴性血培养分离株中50%碳青霉烯耐药,主要菌种为克雷伯菌属(25%)、大肠埃希菌(24%)和不动杆菌属(11%)。全队列住院病死率36.3%,无休克者25.6%,休克者50.8%;平均ICU住院8.64天、总住院11.9天。多因素分析显示充分感染源控制、正确选择经验性抗生素和静脉使用硫胺素为保护因素;入院SOFA评分对不良结局预测较好,院内感染所致脓毒症结局最差。

要点

  • 全队列(n=1172)住院病死率36.3%,无休克者(n=672)25.6%,脓毒症休克者(n=500)50.8%。
  • 培养阳性中65%为革兰阴性菌,革兰阴性血培养分离株中50%碳青霉烯耐药;主要菌种为克雷伯菌属25%、大肠埃希菌24%、不动杆菌属11%。
  • 多因素分析中充分感染源控制、正确选择经验性抗生素和静脉使用硫胺素为保护因素。
  • 入院SOFA评分对不良结局的预测相对较好;院内感染所致脓毒症结局最差。
  • 热带感染(登革热、疟疾、斑疹伤寒)仅占2.2%(n=32),住院病死率低。

适用人群与场景

  • 印度19个ICU收治的成人脓毒症患者,采用Sepsis-3标准(疑似或确诊感染且SOFA评分≥2分),包括脓毒症和脓毒症休克。
  • 排除新冠感染患者。
  • 研究期间为2022年8月至2023年7月,随访至出院或住院死亡。

诊断标准与关键阈值

  • 脓毒症诊断采用Sepsis-3标准:疑似或确诊感染且SOFA评分≥2分。
  • 入院SOFA评分对不良结局的预测相对较好。

处置流程与药物剂量

  • 记录并评估参与中心执行拯救脓毒症指南推荐的绩效改进项目情况。
  • 多因素分析显示充分感染源控制为保护因素。
  • 多因素分析显示正确选择经验性抗生素为保护因素。
  • 多因素分析显示静脉使用硫胺素为保护因素(原文未写明剂量、频次和疗程)。

红旗征与不能漏的情况

  • 脓毒症休克患者病死率高(50.8%)。
  • 院内感染所致脓毒症结局最差。
  • 革兰阴性菌感染占主导且碳青霉烯耐药率高(革兰阴性血培养分离株中50%)。

研究设计与关键结果

  • 研究类型:多中心前瞻性脓毒症登记研究,在印度19个ICU开展,历时一年(2022年8月至2023年7月),纳入1172例脓毒症患者(含500例脓毒症休克),排除新冠感染者。
  • 人群特征:平均年龄65岁,男性61%,平均APACHE II评分21分,平均SOFA评分6.7分;以社区获得性感染为主,肺部感染最常见。
  • 微生物学:培养阳性中65%为革兰阴性菌;革兰阴性血培养分离株中50%碳青霉烯耐药;主要革兰阴性菌为克雷伯菌属(25%)、大肠埃希菌(24%)、不动杆菌属(11%);热带感染(登革热、疟疾、斑疹伤寒)占2.2%(n=32)。
  • 结局:全队列(n=1172)住院病死率36.3%,无休克者(n=672)25.6%,脓毒症休克者(n=500)50.8%;平均ICU住院时间8.64天,平均总住院时间11.9天。
  • 多因素分析:充分感染源控制、正确选择经验性抗生素和静脉使用硫胺素为保护因素;入院SOFA评分对不良结局预测相对较好;院内感染所致脓毒症结局最差。

证据类型、等级与局限

  • 证据类型:多中心前瞻性登记研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为充分感染源控制、正确选择经验性抗生素和静脉使用硫胺素为保护因素。
  • 作者认为入院SOFA评分对不良结局的预测相对较好。
  • 作者认为院内感染所致脓毒症结局最差。

指南或共识出处

  • CTRI注册号:CTRI:2022/07/044516。

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Sepsis is a global health problem with high morbidity and mortality. Low- and middle-income countries have a higher incidence and poorer outcome with sepsis. Large epidemiological studies in sepsis using Sepsis-3 criteria, addressing the process of care and deriving predictors of mortality are scarce in India.

METHOD: A multicentre, prospective sepsis registry was conducted using Sepsis 3 criteria of suspected or confirmed infection and SOFA score of 2 or more in 19 ICUs in India over a period of one year (August 2022-July 2023). All adult patients admitted to the Intensive Care Unit who fulfilled the Sepsis 3 criteria for sepsis and septic shock were included. Patient infected with Covid 19 were excluded. Patients demographics, severity, admission details, initial resuscitation, laboratory and microbiological data and clinical outcome were recorded. Performance improvement programs as recommended by the Surviving Sepsis guideline were noted from the participating centers. Patients were followed till discharge or death while in hospital.

RESULTS: Registry Data of 1172 patients with sepsis (including 500 patients with septic shock) were analysed. The average age of the study cohort was 65 years, and 61% were male. The average APACHE II and SOFA score was 21 and 6.7 respectively. The majority of patients had community-acquired infections, and lung infections were the most common source. Of all culture positive results, 65% were gram negative organism. Carbapenem-resistance was identified in 50% of the gram negative blood culture isolates. The predominant gram negative organisms were Klebsiella spp (25%), Escherechia coli (24%) and Acinetobacter Spp (11%). Tropical infections (Dengue, Malaria, Typhus) constituted minority (n = 32, 2.2%) of sepsis patients. The observed hospital mortality for the entire cohort (n = 1172) was 36.3%, for those without shock (n = 672) it was 25.6% and for those with shock (n = 500) it was 50.8%. The average length of ICU and hospital stay for the study cohort was 8.64 and 11.9 respectively. In multivariate analysis adequate source control, correct choice of empiric antibiotic and the use of intravenous thiamine were protective.

CONCLUSION: The general demographics of the sepsis population in the Indian Sepsis Registry is comparable to Western population. The mortality of sepsis cohort was higher (36.3%) but septic shock mortality (50.8%) was comparable to Western reports. Gram negative infection was the predominant cause of sepsis with a high incidence of carbapenem resistance. Eschericia coli, Klebsiella Spp and Acinetobacter Spp were the predominant causative organism. Tropical infection constituted a minority of sepsis population with low hospital mortality. The SOFA score on admission was a comparatively better predictor of poor outcome. Sepsis secondary to nosocomial infections had the worst outcomes, while source control, correct empirical antibiotic selection, and intravenous thiamine were protective. CTRI Registration CTRI:2022/07/044516.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Todi S, Mehta Y, Zirpe K, et al. A multicentre prospective registry of one thousand sepsis patients admitted in Indian ICUs: (SEPSIS INDIA) study. Crit Care. 2024. PMID: 39563464. doi:10.1186/s13054-024-05176-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。